See every side of every news story
Published loading...Updated

Phantom Neuro Secures $19M Series A Funding Led by Ottobock to Advance Neural Interface Technology for Prosthetics and Robotics

  • Phantom Neuro announced a $19 million Series A round led by Ottobock on April 15, 2025.
  • The funding supports Phantom Neuro's mission to advance its Phantom X robotic control platform.
  • New investors, like Actual VC, joined existing investors to back the company's expanded R&D.
  • Oliver Jakobi, Ottobock CEO, stated Phantom Neuro is transforming assistive devices, calling its technology an exciting step.
  • This investment will help Phantom Neuro complete trials and accelerate regulatory submissions for Phantom X.
Insights by Ground AI
Does this summary seem wrong?

15 Articles

All
Left
Center
4
Right
Denton Record-ChronicleDenton Record-Chronicle
+10 Reposted by 10 other sources
Center

Phantom Neuro Secures $19M Series A Funding Led by Ottobock to Advance Neural Interface Technology for Prosthetics and Robotics

Investment will accelerate clinical trials and commercialization of Phantom X, with Ottobock joining Phantom Neuro's Board of Directors

·Denton, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Device News Magazine broke the news in on Tuesday, April 15, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.